Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Technology Software - Application

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc > Lately

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 03, 2023 2:07am

184 Views

Post# 35264073

RE:RE:RE:RE:RE:Lately

FX gains/losses should be removed from the adj. ebitda calc too as they are similar to one time items that will not repeat.

Foreign exchange, we have already received questions from the financials that we filed last night about the foreign exchange amount on the income statement, which was over $500,000. The reason for that foreign exchange amount, that line item, it just reflects the change in value of the Canadian dollar relative to the U.S. dollar over whatever is our current reporting period. So in this case, it's 3 months ending September 30, 2022. It's really not something to worry about in general, given the strength of the U.S. dollar and the trends that are suggesting that the U.S. dollar is going to stay very strong relative to the Canadian dollar.

	USD - CAD rate
Jun30/22	1.2886
Sep30/22	1.3707
Dec21/22	1.3544

Qtr ending	Sep 22
Loss	(122,475)
Stock comp	710,501
Accretion/amort	33,422
Unrealized fx	(13,462)
1 time costs?	2,426
Reported adj. ebitda	610,412
FX gain	(530,246)
Adj ebitda	80,166